# OnCo record biogen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biogen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biogen" ;
  schema:name "Biogen"@en ;
  schema:alternateName "Biogen Inc."@en, "Biogen Idec"@en, "IDEC Pharmaceuticals"@en ;
  schema:description "Biogen is the Massachusetts biotech that, as Biogen Idec, co-developed rituximab, the first antibody approved for cancer; it now concentrates on neurology."@en ;
  schema:url <https://onco.cc/companies/biogen/>, <https://www.biogen.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Biogen> ;
  owl:sameAs <http://www.wikidata.org/entity/Q864338> ;
  schema:citation <https://www.biogen.com>, <https://clinicaltrials.gov/search?lead=Biogen>, <https://www.wikidata.org/wiki/Q864338> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> .